ABBIE MORGAN: Open Payments
NPI 1093498305 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$785 in 37 payments from 13 companies in 2025. Trend: 2023 $159 · 2024 $1,809 · 2025 $785
Food & beverage: $785
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $176 |
| Janssen Biotech, Inc. | 5 | $146 |
| ABBVIE INC. | 6 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $71 |
| Intercept Pharmaceuticals, Inc. | 3 | $68 |
| GENZYME CORPORATION | 2 | $60 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Gilead Sciences, Inc. | 1 | $22 |
| QOL Medical, LLC | 1 | $18 |
| PFIZER INC. | 1 | $16 |
Products named: XIFAXAN, TREMFYA, OCALIVA, DUPIXENT, ENTYVIO, SKYRIZI, VOQUEZNA, RINVOQ.
Industry payments across NC — which companies pay providers there.
